美国食品和药物管理局批准Omnipod 5自动化胰岛素输送系统用于2型糖尿病成年人. FDA approves Omnipod 5 automated insulin delivery system for adults with Type 2 diabetes.

美国食品和药物管理局批准了Insulet的Omnipod 5自动化胰岛素输送系统,用于2型糖尿病的成年人,扩大了其最初用于1型糖尿病的用途. The FDA has approved Insulet's Omnipod 5 automated insulin delivery system for adults with Type 2 diabetes, expanding its initial use for Type 1 diabetes. Omnipod 5系统连接到一个由控制器带动的替代胰岛素泵和综合连续葡萄糖监测器,为没有针头的糖尿病管理提供了最多三天的非侵入性选择。 The Omnipod 5 system connects to an alternate controller-enabled insulin pump and integrated continuous glucose monitor, providing a non-invasive option for diabetes management without needles for up to three days. 食品药品管理局的决定旨在增加美国数百万患有2型糖尿病的成年人获得糖尿病管理工具的机会。 The FDA's decision aims to increase access to diabetes management tools for millions of adults with Type 2 diabetes in the US.